vs
Side-by-side financial comparison of ANAPTYSBIO, INC (ANAB) and MEDALLION FINANCIAL CORP (MFIN). Click either name above to swap in a different company.
ANAPTYSBIO, INC is the larger business by last-quarter revenue ($108.2M vs $70.6M, roughly 1.5× MEDALLION FINANCIAL CORP). ANAPTYSBIO, INC runs the higher net margin — 45.8% vs 17.3%, a 28.5% gap on every dollar of revenue. On growth, ANAPTYSBIO, INC posted the faster year-over-year revenue change (151.1% vs 25.4%). Over the past eight quarters, ANAPTYSBIO, INC's revenue compounded faster (288.3% CAGR vs 15.0%).
AnaptysBio, Inc. is a clinical-stage biotechnology company focused on developing antibody-based immunotherapies for inflammatory diseases, immuno-oncology indications, and rare disease conditions. It primarily serves the U.S. market, advancing its innovative product candidate pipeline to address unmet medical needs via rigorous research and clinical development.
Mahindra & Mahindra Financial Services Limited (MMFSL) is an Indian rural non-banking financial company headquartered in Mumbai. It is amongst the top tractor financers in India, with 1000+ offices across the country.
ANAB vs MFIN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $108.2M | $70.6M |
| Net Profit | $49.6M | $12.2M |
| Gross Margin | — | — |
| Operating Margin | 61.8% | 29.3% |
| Net Margin | 45.8% | 17.3% |
| Revenue YoY | 151.1% | 25.4% |
| Net Profit YoY | 327.8% | 20.3% |
| EPS (diluted) | $1.64 | $0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $108.2M | $70.6M | ||
| Q3 25 | $76.3M | $58.7M | ||
| Q2 25 | $22.3M | $62.6M | ||
| Q1 25 | $27.8M | $63.0M | ||
| Q4 24 | $43.1M | $56.3M | ||
| Q3 24 | $30.0M | $53.3M | ||
| Q2 24 | $11.0M | $51.0M | ||
| Q1 24 | $7.2M | $53.3M |
| Q4 25 | $49.6M | $12.2M | ||
| Q3 25 | $15.1M | $7.8M | ||
| Q2 25 | $-38.6M | $11.1M | ||
| Q1 25 | $-39.3M | $12.0M | ||
| Q4 24 | $-21.8M | $10.1M | ||
| Q3 24 | $-32.9M | $8.6M | ||
| Q2 24 | $-46.7M | $7.1M | ||
| Q1 24 | $-43.9M | $10.0M |
| Q4 25 | 61.8% | 29.3% | ||
| Q3 25 | 45.5% | 33.2% | ||
| Q2 25 | -117.5% | 31.1% | ||
| Q1 25 | -99.2% | 32.1% | ||
| Q4 24 | -22.4% | 32.8% | ||
| Q3 24 | -75.8% | 26.6% | ||
| Q2 24 | -367.5% | 24.3% | ||
| Q1 24 | -587.8% | 33.6% |
| Q4 25 | 45.8% | 17.3% | ||
| Q3 25 | 19.8% | 13.2% | ||
| Q2 25 | -173.5% | 17.7% | ||
| Q1 25 | -141.6% | 19.1% | ||
| Q4 24 | -50.5% | 18.0% | ||
| Q3 24 | -109.4% | 16.1% | ||
| Q2 24 | -425.3% | 13.9% | ||
| Q1 24 | -612.0% | 18.8% |
| Q4 25 | $1.64 | $0.50 | ||
| Q3 25 | $0.52 | $0.32 | ||
| Q2 25 | $-1.34 | $0.46 | ||
| Q1 25 | $-1.28 | $0.50 | ||
| Q4 24 | $-0.63 | $0.43 | ||
| Q3 24 | $-1.14 | $0.37 | ||
| Q2 24 | $-1.71 | $0.30 | ||
| Q1 24 | $-1.64 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $238.2M | $136.3M |
| Total DebtLower is stronger | — | $216.0M |
| Stockholders' EquityBook value | $37.2M | $408.6M |
| Total Assets | $364.4M | $3.0B |
| Debt / EquityLower = less leverage | — | 0.53× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $238.2M | $136.3M | ||
| Q3 25 | $109.8M | $72.5M | ||
| Q2 25 | $44.3M | $110.4M | ||
| Q1 25 | $98.6M | $131.5M | ||
| Q4 24 | $123.1M | $98.2M | ||
| Q3 24 | $191.6M | $120.6M | ||
| Q2 24 | $71.8M | $87.7M | ||
| Q1 24 | $53.7M | $54.8M |
| Q4 25 | — | $216.0M | ||
| Q3 25 | — | $215.7M | ||
| Q2 25 | — | $199.9M | ||
| Q1 25 | — | $199.7M | ||
| Q4 24 | — | $232.2M | ||
| Q3 24 | — | $232.0M | ||
| Q2 24 | — | $230.8M | ||
| Q1 24 | — | $225.6M |
| Q4 25 | $37.2M | $408.6M | ||
| Q3 25 | $-29.4M | $397.4M | ||
| Q2 25 | $-44.7M | $389.9M | ||
| Q1 25 | $34.0M | $380.2M | ||
| Q4 24 | $70.9M | $370.2M | ||
| Q3 24 | $84.4M | $362.4M | ||
| Q2 24 | $9.9M | $354.0M | ||
| Q1 24 | $47.8M | $349.0M |
| Q4 25 | $364.4M | $3.0B | ||
| Q3 25 | $353.1M | $2.9B | ||
| Q2 25 | $335.3M | $2.9B | ||
| Q1 25 | $422.1M | $2.8B | ||
| Q4 24 | $483.8M | $2.9B | ||
| Q3 24 | $493.4M | $2.9B | ||
| Q2 24 | $427.4M | $2.8B | ||
| Q1 24 | $405.8M | $2.6B |
| Q4 25 | — | 0.53× | ||
| Q3 25 | — | 0.54× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | 0.53× | ||
| Q4 24 | — | 0.63× | ||
| Q3 24 | — | 0.64× | ||
| Q2 24 | — | 0.65× | ||
| Q1 24 | — | 0.65× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $98.0M | $126.3M |
| Free Cash FlowOCF − Capex | $98.0M | — |
| FCF MarginFCF / Revenue | 90.5% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | 1.98× | 10.35× |
| TTM Free Cash FlowTrailing 4 quarters | $19.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $98.0M | $126.3M | ||
| Q3 25 | $-27.4M | $67.0M | ||
| Q2 25 | $-40.2M | $-10.7M | ||
| Q1 25 | $-10.7M | $36.3M | ||
| Q4 24 | $-66.7M | $108.7M | ||
| Q3 24 | $-10.1M | $24.6M | ||
| Q2 24 | $-21.3M | $27.6M | ||
| Q1 24 | $-37.3M | $32.3M |
| Q4 25 | $98.0M | — | ||
| Q3 25 | $-27.4M | — | ||
| Q2 25 | $-40.3M | — | ||
| Q1 25 | $-10.7M | — | ||
| Q4 24 | $-66.9M | — | ||
| Q3 24 | $-10.1M | — | ||
| Q2 24 | $-21.4M | — | ||
| Q1 24 | $-37.3M | — |
| Q4 25 | 90.5% | — | ||
| Q3 25 | -35.9% | — | ||
| Q2 25 | -180.9% | — | ||
| Q1 25 | -38.7% | — | ||
| Q4 24 | -155.3% | — | ||
| Q3 24 | -33.7% | — | ||
| Q2 24 | -194.6% | — | ||
| Q1 24 | -519.3% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 0.4% | — |
| Q4 25 | 1.98× | 10.35× | ||
| Q3 25 | -1.81× | 8.63× | ||
| Q2 25 | — | -0.97× | ||
| Q1 25 | — | 3.02× | ||
| Q4 24 | — | 10.72× | ||
| Q3 24 | — | 2.86× | ||
| Q2 24 | — | 3.89× | ||
| Q1 24 | — | 3.22× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
